Bioavailability, Bioequivalence & Bioethics

The concept of BE has been accepted worldwide by the pharmaceutical industry and national regulatory authorities for over 20 years and is applied to new as well as generic products. As a result, thousands of high-quality generic drugs at reduced costs have become available in every corner of the globe. The assessment of BE is not a simple issue, however, and much of the research has been done in recent years to develop new and more effective approaches to the assessment of BE.

Since then, and after turn of the century, tremendous advancements have been made by the FDA and other regulatory authorities (national, international, and supranational), and by industry and academia in the area of assessment of bioequivalence. Currently approaches to determine BE of pharmaceutical products has been largely standardized. This has occurred due to discussion and consensus reached among various stakeholders at numerous national and international meetings, conferences, and workshops.

The pharmaceutical firms all over the world are burning the candle at both ends for attainment of market authorizations in various nations.

Bioethics can evaluate global justice by weighing human rights theory and future innovation at the macro level, and by addressing market forces and responsibilities at the micro level. Inherent structural features of pharmaceuticals, such as its reliance on research and development, cause the industry to employ pricing strategies that seem counter-intuitive to conventional wisdom, but that result in producing a just allocation as defined by market forces.

  • Scope of Guidelines
  • Pharmacokinetic and Pharmacodynamic Studies
  • In-Vitri and In Vivo Studoies
  • Bioethical challenges of new technology

Related Conference of Bioavailability, Bioequivalence & Bioethics

August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
August 27-28, 2025

20th World Congress on Drug Formulation & Drug Delivery

Amsterdam, Netherlands
September 19-20, 2025

18th World Drug Delivery Summit

Paris, France
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 24-25, 2025

5th World Congress on Rare Diseases & Orphan Drugs

Aix-en-Provence, France
October 23-24, 2025

21st Annual Meet on Pharmaceutical Sciences

Aix-en-Provence, France
November 11-12, 2025

6th Annual Congress on Antibiotics and Bacterial Infections

Amsterdam, Netherlands
November 13-14, 2025

21st International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
December 01-02, 2025

13th International Conference on Clinical Trials

Vancouver, Canada
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, Aland Islands
March 23-24, 2026

36th Annual European Pharma Congress

London, UK
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands
May 21-22, 2026

8th International Conference and Exhibition on Pain Management

Aix-en-Provence, France
May 28-29, 2026

3rd International Conference on Pharmacognosy

Madrid, Spain
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy

Bioavailability, Bioequivalence & Bioethics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in